Correction: TGF-β prevents phosphate-induced osteogenesis through inhibition of BMP and Wnt/β-catenin pathways (PLoS ONE (2014) 9, 2 (e89179) DOI: 10.1371/journal.pone.0089179);TGF-β prevents phosphate-induced osteogenesis through inhibition of BMP and Wnt/β-catenin pathways

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Guerrero, Fátima ^a   Herencia, Carmen ^a   Almadén, Yolanda ^a   Martínez Moreno, Julio M ^a   Montes De Oca, Addy ^a   Rodriguez Ortiz, María Encarnación ^a   Diaz Tocados, Juan M ^a   Canalejo, Antonio ^b   Florio, Mónica ^c   López, Ignacio ^a   Richards, William G ^c   Rodriguez, Mariano ^a   Aguilera Tejero, Escolástico ^a   Muñoz Castañeda, Juan R ^a  

^a UNIVERSITY OF CÓRDOBA   (Spain)

^b UNIVERSITY OF HUELVA   (Spain)

^c AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; ALPHA SMOOTH MUSCLE ACTIN; BETA CATENIN; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2; CALCIUM; DICKKOPF 1 PROTEIN; LITHIUM CHLORIDE; MYOCARDIN; MYOSIN HEAVY CHAIN; PHOSPHATE; SMAD1 PROTEIN; SMAD3 PROTEIN; SMAD5 PROTEIN; SMAD8 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSGELIN; WNT PROTEIN;

ANIMAL CELL; ARTICLE; BONE DEVELOPMENT; CELL DIFFERENTIATION; CELL ISOLATION; CONTROLLED STUDY; ENZYME ACTIVITY; HEMATOPOIETIC STEM CELL; IMMUNOPHENOTYPING; MALE; MOLECULAR INTERACTION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

ANIMALS; BETA CATENIN; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEINS; CELL DIFFERENTIATION; CELL NUCLEUS; GENE EXPRESSION PROFILING; IMMUNOPHENOTYPING; MALE; MESENCHYMAL STROMAL CELLS; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; OSTEOGENESIS; PHOSPHATES; PROTEIN TRANSPORT; RATS; SIGNAL TRANSDUCTION; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; WNT PROTEINS;

EID: 84896120391     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0101910     Document Type: Erratum

References (36)

1. London GM, Guerin AP, Marchais SJ, Metivier F, Pannier B, et al. (2003) Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 18: 1731-1740. (Pubitemid 37098542)
2. Kalra SS, Shanahan CM (2012) Vascular calcification and hypertension: cause and effect. Ann Med 44 Suppl 1: S85-S92.
3. Jono S, McKee MD, Murry CE, Shioi A, Nishizawa Y, et al. (2000) Phosphate regulation of vascular smooth muscle cell calcification. Circ Res 87: E10-E17.
4. Iyemere VP, Proudfoot D, Weissberg PL, Shanahan CM (2006) Vascular smooth muscle cell phenotypic plasticity and the regulation of vascular calcification. J Intern Med 260: 192-210. (Pubitemid 44253633)
5. Sage AP, Lu J, Tintut Y, Demer LL (2011) Hyperphosphatemia-induced nanocrystals upregulate the expression of bone morphogenetic protein-2 and osteopontin genes in mouse smooth muscle cells in vitro. Kidney Int 79: 414-422.
6. Montes de OA, Madueno J, Martinez J, Guerrero F, Munoz-Castaneda J, et al. (2010) High phosphate-induced calcification is related to SM22alpha promoter methylation in Vascular Smooth Muscle Cells. J Bone Miner Res 25: 1996-2005.
7. Giachelli CM (2004) Vascular calcification mechanisms. J Am Soc Nephrol 15: 2959-2964.
8. Oswald J, Boxberger S, Jorgensen B, Feldmann S, Ehninger G, et al. (2004) Mesenchymal stem cells can be differentiated into endothelial cells in vitro. Stem Cells 22: 377-384. (Pubitemid 38736621)
9. Kurpinski K, Lam H, Chu J, Wang A, Kim A, et al. (2010) Transforming growth factor-beta and notch signaling mediate stem cell differentiation into smooth muscle cells. Stem Cells 28: 734-742.
10. Li X, Yang HY, Giachelli CM (2008) BMP-2 promotes phosphate uptake, phenotypic modulation, and calcification of human vascular smooth muscle cells. Atherosclerosis 199: 271-277.
11. Tang Y, Urs S, Boucher J, Bernaiche T, Venkatesh D, et al. (2010) Notch and transforming growth factor-beta (TGFbeta) signaling pathways cooperatively regulate vascular smooth muscle cell differentiation. J Biol Chem 285: 17556-17563.
12. Qiu P, Ritchie RP, Fu Z, Cao D, Cumming J, et al. (2005) Myocardin enhances Smad3-mediated transforming growth factor-beta1 signaling in a CArG box-independent manner: Smad-binding element is an important cis element for SM22alpha transcription in vivo. Circ Res 97: 983-991. (Pubitemid 41668911)
13. Cao X, Chen D (2005) The BMP signaling and in vivo bone formation. Gene 357: 1-8. (Pubitemid 41267309)
14. Yu Z, Seya K, Daitoku K, Motomura S, Fukuda I, et al. (2010) TNF-α accelerates the calcification of human aortic valve interstitial cells obtained from patients with calcific aortic valve stenosis via the BMP2-Dlx5 pathway. J Pharmacol Exp Ther 337: 16-23.
15. Edgar CM, Chakravarthy V, Barnes G, Kakar S, Gerstenfeld LC, et al. (2007) Autogenous regulation of a network of bone morphogenetic proteins (BMPs) mediates the osteogenic differentiation in murine marrow stromal cells. Bone 40:1389-1398. (Pubitemid 46550983)
16. Kramann R, Couson SK, Neuss S, Kunter U, Bovi M, et al. (2011) Exposure to uremic serum induces a procalcific phenotype in human mesenchymal stem cells. Arterioscler Thromb Vasc Biol 31: e45-e54.
17. Bostrom K, Watson KE, Horn S, Wortham C, Herman IM, et al. (1993) Bone morphogenetic protein expression in human atherosclerotic lesions. J Clin Invest 91: 1800-1809. (Pubitemid 23127387)
18. Hayashi K, Nakamura S, Nishida W, Sobue K (2006) Bone morphogenetic protein-induced MSX1 and MSX2 inhibit myocardin-dependent smooth muscle gene transcription. Mol Cell Biol 26: 9456-9470. (Pubitemid 44904438)
19. Shao JS, Cheng SL, Pingsterhaus JM, Charlton-Kachigian N, Loewy AP, et al. (2005) Msx2 promotes cardiovascular calcification by activating paracrine Wnt signals. J Clin Invest 115: 1210-1220. (Pubitemid 40629039)
20. Yagi K, Tsuji K, Nifuji A, Shinomiya K, Nakashima K, et al. (2003) Bone morphogenetic protein-2 enhances osterix gene expression in chondrocytes. J Cell Biochem 88: 1077-1083. (Pubitemid 36397446)
21. Shalhoub V, Shatzen EM, Ward SC, Young JI, Boedigheimer M, et al. (2010) Chondro/osteoblastic and cardiovascular gene modulation in human artery smooth muscle cells that calcify in the presence of phosphate and calcitriol or paricalcitol. J Cell Biochem 111: 911-921.
22. Davies MR, Lund RJ, Hruska KA (2003) BMP-7 is an efficacious treatment of vascular calcification in a murine model of atherosclerosis and chronic renal failure. J Am Soc Nephrol 14: 1559-1567. (Pubitemid 36687057)
23. Lee KM, Kang HA, Park M, Lee HY, Choi HR, et al. (2012) Interleukin-24 attenuates beta-glycerophosphate-induced calcification of vascular smooth muscle cells by inhibiting apoptosis, the expression of calcification and osteoblastic markers, and the Wnt/beta-catenin pathway. Biochem Biophys Res Commun 428: 50-55.
24. Martinez-Moreno JM, Munoz-Castaneda JR, Herencia C, Oca AM, Estepa JC, et al. (2012) In vascular smooth muscle cells paricalcitol prevents phosphate-induced Wnt/beta-catenin activation. Am J Physiol Renal Physiol 303: F1136-F1144.
25. Li RD, Deng ZL, Hu N, Liang X, Liu B, et al. (2012) Biphasic effects of TGFbeta1 on BMP9-induced osteogenic differentiation of mesenchymal stem cells. BMB Rep 45: 509-514.
26. Lian N, Lin T, Liu W, Wang W, Li L, et al. (2012) Transforming growth factor beta suppresses osteoblast differentiation via the vimentin activating transcription factor 4 (ATF4) axis. J Biol Chem 287: 35975-35984.
27. Ehnert S, Zhao J, Pscherer S, Freude T, Dooley S, et al. (2012) Transforming growth factor beta1 inhibits bone morphogenic protein (BMP)-2 and BMP-7 signaling via upregulation of Ski-related novel protein N (SnoN): possible mechanism for the failure of BMP therapy? BMC Med 10: 101.
28. Miyoshi H, Ajima R, Luo CT, Yamaguchi TP, Stappenbeck TS (2012) Wnt5a potentiates TGF-beta signaling to promote colonic crypt regeneration after tissue injury. Science 338: 108-113.
29. Roarty K, Baxley SE, Crowley MR, Frost AR, Serra R (2009) Loss of TGF-beta or Wnt5a results in an increase in Wnt/beta-catenin activity and redirects mammary tumour phenotype. Breast Cancer Res 11: R19.
30. Zhou S (2011) TGF-beta regulates beta-catenin signaling and osteoblast differentiation in human mesenchymal stem cells. J Cell Biochem 112: 1651-1660.
31. Itasaki N, Hoppler S (2010) Crosstalk between Wnt and bone morphogenic protein signaling: a turbulent relationship. Dev Dyn 239: 16-33.
32. Rawadi G, Vayssiere B, Dunn F, Baron R, Roman-Roman S (2003) BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop. J Bone Miner Res 18: 1842-1853. (Pubitemid 37322562)
33. Zhang R, Oyajobi BO, Harris SE, Chen D, Tsao C, et al. (2013) Wnt/beta-catenin signaling activates bone morphogenetic protein 2 expression in osteoblasts. Bone 52: 145-156.
34. Lopez I, Mendoza FJ, Guerrero F, Almaden Y, Henley C, et al. (2009) The calcimimetic AMG 641 accelerates regression of extraosseous calcification in uremic rats. Am J Physiol Renal Physiol 296: F1376-F1385.
35. Wilkinson FL, Liu Y, Rucka AK, Jeziorska M, Hoyland JA, et al. (2007) Contribution of VCAF-positive cells to neovascularization and calcification in atherosclerotic plaque development. J Pathol 211: 362-369. (Pubitemid 46172712)
36. Zhang C, Zeng L, Emanueli C, Xu Q (2013) Blood Flow and Stem Cells in Vascular Disease. Cardiovasc Res 15; 99: 251-259.